F447-0271 Screening compound: 6-(2,5-dimethylbenzenesulfonamido)-2-[4-(pyrimidin-2-yl)piperazin-1-yl]quinoline-4-carboxylic acid

F447-0271 Screening compound: 6-(2,5-dimethylbenzenesulfonamido)-2-[4-(pyrimidin-2-yl)piperazin-1-yl]quinoline-4-carboxylic acid
F447-0271 Screening compound: 6-(2,5-dimethylbenzenesulfonamido)-2-[4-(pyrimidin-2-yl)piperazin-1-yl]quinoline-4-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound F447-0271
6-(2,5-dimethylbenzenesulfonamido)-2-[4-(pyrimidin-2-yl)piperazin-1-yl]quinoline-4-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F447-0271

Molecular Formula

C26H26N6O4S (C26 H26 N6 O4 S)

Compound Name

6-(2,5-dimethylbenzenesulfonamido)-2-[4-(pyrimidin-2-yl)piperazin-1-yl]quinoline-4-carboxylic acid

IUPAC name

6-(25-dimethylbenzenesulfonamido)-2-[4-(pyrimidin-2-yl)piperazin-1-yl]quinoline-4-carboxylic acid

SMILES

Cc1cc(S(Nc(ccc2nc(N(CC3)CCN3c3ncccn3)c3)cc2c3C(O)=O)(=O)=O)c(C)cc1

InChI

InChI=1S/C26H26N6O4S/c1-17-4-5-18(2)23(14-17)37(35,36)30-19-6-7-22-20(15-19)21(25(33)34)16-24(29-22)31-10-12-32(13-11-31)26-27-8-3-9-28-26/h3-9,14-16,30H,10-13H2,1-2H3,(H,33,34)

InChI Key

AZYAPGPPMYYFSW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14954552

Chemical and Physical Properties

Saltdata

3HCl

Molecular Weight

518.6

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

5.427

Distribution Coefficient, logD

2.483

Water Solubility, LogSw

-5.23

Polar Surface Area

102.165

Acid Dissociation Constant (pKa)

4.46

Base Dissociation Constant (pKb)

4.30

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.10

F447-0271 in Drug Discovery

Included in Screening Libraries

Integrin Receptors Targeted library (1715 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Others

References: we are preparing a list of scientific research reports with F447-0271 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F447-0271?
Check Price and Availability of F447-0271, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F447-0271 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F447-0271
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F447-0271
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F447-0271 available by request